Literature DB >> 23680151

Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation.

Mo Li1, Xiaochun Yu.   

Abstract

Carriers of BRCA1 germline mutations are predisposed to breast and ovarian cancers. Accumulated evidence shows that BRCA1 is quickly recruited to DNA lesions and plays an important role in the DNA damage response. However, the mechanism by which BRCA1 is recruited to DNA damage sites remains elusive. BRCA1 forms a Ring-domain heterodimer with BARD1, a major partner of BRCA1 that contains tandem BRCA1 C-terminus (BRCT) motifs. Here, we identify the BRCTs of BARD1 as a poly(ADP-ribose) (PAR)-binding module. The binding of the BARD1 BRCTs to PAR targets the BRCA1/BARD1 heterodimer to DNA damage sites. Thus, our study uncovers a PAR-dependent mechanism of rapid recruitment of BRCA1/BARD1 to DNA damage sites.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23680151      PMCID: PMC3759356          DOI: 10.1016/j.ccr.2013.03.025

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  72 in total

1.  Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.

Authors:  Maria Rodriguez; Xiaochun Yu; Junjie Chen; Zhou Songyang
Journal:  J Biol Chem       Date:  2003-10-24       Impact factor: 5.157

2.  Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.

Authors:  Maria Victoria E Botuyan; Yves Nominé; Xiaochun Yu; Nenad Juranic; Slobodan Macura; Junjie Chen; Georges Mer
Journal:  Structure       Date:  2004-07       Impact factor: 5.006

3.  A specific, low Km ADP-ribose pyrophosphatase from rat liver.

Authors:  A Miró; M J Costas; M García-Díaz; M T Hernández; J C Cameselle
Journal:  FEBS Lett       Date:  1989-02-13       Impact factor: 4.124

4.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

5.  Specific ADP-ribose pyrophosphatase from Artemia cysts and rat liver: effects of nitroprusside, fluoride and ionic strength.

Authors:  A Fernández; J M Ribeiro; M J Costas; R M Pinto; J Canales; J C Cameselle
Journal:  Biochim Biophys Acta       Date:  1996-05-21

6.  Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.

Authors:  R Scott Williams; Megan S Lee; D Duong Hau; J N Mark Glover
Journal:  Nat Struct Mol Biol       Date:  2004-05-09       Impact factor: 15.369

7.  Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.

Authors:  Julie A Clapperton; Isaac A Manke; Drew M Lowery; Timmy Ho; Lesley F Haire; Michael B Yaffe; Stephen J Smerdon
Journal:  Nat Struct Mol Biol       Date:  2004-05-09       Impact factor: 15.369

8.  High resolution fractionation and characterization of ADP-ribose polymers.

Authors:  C C Kiehlbauch; N Aboul-Ela; E L Jacobson; D P Ringer; M K Jacobson
Journal:  Anal Biochem       Date:  1993-01       Impact factor: 3.365

9.  Inhibition and ADP-ribose pyrophosphatase-I by nitric-oxide-generating systems: a mechanism linking nitric oxide to processes dependent on free ADP-ribose.

Authors:  J M Ribeiro; J C Cameselle; A Fernández; J Canales; R M Pinto; M J Costas
Journal:  Biochem Biophys Res Commun       Date:  1995-08-24       Impact factor: 3.575

Review 10.  Hallmarks of 'BRCAness' in sporadic cancers.

Authors:  Nicholas Turner; Andrew Tutt; Alan Ashworth
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

View more
  137 in total

Review 1.  Spatiotemporal regulation of posttranslational modifications in the DNA damage response.

Authors:  Nico P Dantuma; Haico van Attikum
Journal:  EMBO J       Date:  2015-12-01       Impact factor: 11.598

2.  ZNF365 promotes stalled replication forks recovery to maintain genome stability.

Authors:  Yuqing Zhang; Eunmi Park; Christopher S Kim; Ji-hye Paik
Journal:  Cell Cycle       Date:  2013-08-06       Impact factor: 4.534

Review 3.  ADP-ribosyltransferases and poly ADP-ribosylation.

Authors:  Chao Liu; Xiaochun Yu
Journal:  Curr Protein Pept Sci       Date:  2015       Impact factor: 3.272

Review 4.  Deciphering the BRCA1 Tumor Suppressor Network.

Authors:  Qinqin Jiang; Roger A Greenberg
Journal:  J Biol Chem       Date:  2015-06-05       Impact factor: 5.157

5.  Characterization of LGALS3 (galectin-3) as a player in DNA damage response.

Authors:  Renato S Carvalho; Vanessa C Fernandes; Thales C Nepomuceno; Deivid C Rodrigues; Nicholas T Woods; Guilherme Suarez-Kurtz; Roger Chammas; Alvaro N Monteiro; Marcelo A Carvalho
Journal:  Cancer Biol Ther       Date:  2014-04-22       Impact factor: 4.742

Review 6.  Crosstalk between ubiquitin and other post-translational modifications on chromatin during double-strand break repair.

Authors:  Yu Zhao; Joshua R Brickner; Mona C Majid; Nima Mosammaparast
Journal:  Trends Cell Biol       Date:  2014-02-23       Impact factor: 20.808

7.  Poly(ADP-ribosyl)ation is recognized by ECT2 during mitosis.

Authors:  Mo Li; Chunjing Bian; Xiaochun Yu
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 8.  BRCA1 gene variant p.P142H associated with male breast cancer: a two-generation genealogic study and literature review.

Authors:  Claudio Spinelli; Silvia Strambi; Lorenzo Piccini; Leonardo Rossi; Paolo Aretini; Adelaide Caligo
Journal:  Fam Cancer       Date:  2015-12       Impact factor: 2.375

Review 9.  PARP-1 and its associated nucleases in DNA damage response.

Authors:  Yijie Wang; Weibo Luo; Yingfei Wang
Journal:  DNA Repair (Amst)       Date:  2019-07-08

10.  Differential requirements for DNA repair proteins in immortalized cell lines using alternative lengthening of telomere mechanisms.

Authors:  Alaina R Martinez; Zeenia Kaul; Jeffrey D Parvin; Joanna Groden
Journal:  Genes Chromosomes Cancer       Date:  2017-05-31       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.